Prof. Timothy W. Corson is Professor and Co-Director, Graduate Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Canada. He is also a Professor of Ophthalmology and Vision Sciences and an Affiliate Scientist at the Donald K. Johnson Eye Institute, University Health Network. He holds HonBSc, MSc, and PhD degrees from the University of Toronto, and completed a postdoc at Yale University before establishing his lab at Indiana University School of Medicine in the Department of Ophthalmology, where he became Vice-Chair for Basic and Translational Research, before serving as Chair of the Department of Pharmacology and Toxicology. His lab focuses on mechanistic and therapeutic studies for ocular neovascular diseases and ocular tumors. He is an author on over 100 publications and an inventor on 12 patents. His lab is currently supported by NSERC, CFI, NIH, and foundation grants. Selected awards include the Merrill Grayson Senior Chair and a Showalter Scholar at the Indiana University School of Medicine, Entrepreneur-in-Residence at the Indiana Center for Biomedical Innovation, and a Watanabe Translational Scholar of the Indiana Clinical and Translational Sciences Institute. He is on the editorial board of several journals and currently serves as Chair of the NIH Pathobiology of Eye Disease 1 study section (review panel) as well as reviewing for public and private funders in the US, Canada, UK, Europe, and Australasia.